#027​ - Serena Mandla // Quthero

Quthero is committed to disrupting the ways we treat wounds today – from passive ‘dressing’ of wounds to active, rapid, healthy wound management.

#027​ - Serena Mandla // Quthero

Serena graduated from the University of Toronto with a Master’s degree in Biomaterials and Biomedical Engineering. Her research focuses on biomaterials for immune system activation and wound healing.  

Together with her professor, she is commercializing the biomaterial as part of a new start up company, Quthero. The company takes inspiration from nature, and is trying to change how we heal wounds with their wound gel, which accelerates healing and reduces scarring.  

Quthero is committed to disrupting the ways we treat wounds today – from passive ‘dressing’ of wounds to active, rapid, healthy wound management.  

They have developed novel, effective and safe treatments for all types of wounds including wounds from cosmetic procedures, surgical wounds, burns, and chronic ulcers to effectively manage wounds and reduce complications and risks associated with slow healing (infection, pain, amputation and mortality).  

Quthero’s patented platform technology enables full epithelial restoration, helping to close wounds quickly and with minimal scarring.  Their novel wound management gel treats wounds in a potent, paradigm-shifting way with only a single application. This has been demonstrated in multiple pre-clinical animal models and human skin, where Quthero-treated wounds healed with minimal scarring and 60-200% faster than the wounds treated with currently marketed products.  

Quthero’s platform technology effectively manages wounds in tissues other than skin as validated in cardiovascular, endothelial, cutaneous tissue, osteoblasts and hiPSC and published in 9 peer-reviewed articles.

Watch on YouTube
Listen on Spotify

Episode Description

Serena graduated from the University of Toronto with a Master’s degree in Biomaterials and Biomedical Engineering. Her research focuses on biomaterials for immune system activation and wound healing.  

Together with her professor, she is commercializing the biomaterial as part of a new start up company, Quthero. The company takes inspiration from nature, and is trying to change how we heal wounds with their wound gel, which accelerates healing and reduces scarring.  

Quthero is committed to disrupting the ways we treat wounds today – from passive ‘dressing’ of wounds to active, rapid, healthy wound management.  

They have developed novel, effective and safe treatments for all types of wounds including wounds from cosmetic procedures, surgical wounds, burns, and chronic ulcers to effectively manage wounds and reduce complications and risks associated with slow healing (infection, pain, amputation and mortality).  

Quthero’s patented platform technology enables full epithelial restoration, helping to close wounds quickly and with minimal scarring.  Their novel wound management gel treats wounds in a potent, paradigm-shifting way with only a single application. This has been demonstrated in multiple pre-clinical animal models and human skin, where Quthero-treated wounds healed with minimal scarring and 60-200% faster than the wounds treated with currently marketed products.  

Quthero’s platform technology effectively manages wounds in tissues other than skin as validated in cardiovascular, endothelial, cutaneous tissue, osteoblasts and hiPSC and published in 9 peer-reviewed articles.

Subscribe to 🔱 Disrupt

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe

Subscribe